Article

Risk counseling important for cataract candidates with history of optic neuropathy

An optic neuropathy resembling nonarteritic ischemic optic neuropathy (NAION) may occur after apparently uncomplicated cataract extraction at a rate higher than would be expected in the general population, said Neil R. Miller, MD. Dr. Miller is professor?ophthalmology, neurology, and neurosurgery, and Frank B. Walsh Professor of Neuro-Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore.

An optic neuropathy resembling nonarteritic ischemic optic neuropathy (NAION) may occur after apparently uncomplicated cataract extraction at a rate higher than would be expected in the general population, said Neil R. Miller, MD. Dr. Miller is professor-ophthalmology, neurology, and neurosurgery, and Frank B. Walsh Professor of Neuro-Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore.

The rate of optic neuropathy in the first 6 months after cataract extraction is estimated to be about 52 per 100,000 cases. According to results of the Ischemic Optic Neuropathy Decompression Trial, patients with unilateral NAION have about a 15% to 20% 5-year risk of the same event in a fellow eye. Cataract extraction increases this risk two to eight times, Dr. Miller said.

It is thought two types of NAION can occur post-cataract extraction: an immediate event that may be associated with elevated intraoperative IOP and a delayed type that may be more related to the same risk factors as NAION.

Judicious control of IOP during surgery may reduce the risk of the immediate type of post-cataract extraction optic neuropathy. However, there appears to be no way to prevent the delayed event.

"We need to talk to our patients," Dr. Miller urged. "Patients who developed an optic neuropathy after first eye cataract surgery should be told there is an increased risk of this event if cataract extraction is performed in the fellow eye. Those patients with spontaneous NAION in one eye should also be told they have an increased risk following cataract extraction in the fellow eye."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.